AJP - Renal Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol (January 4, 2005). doi:10.1152/ajprenal.00370.2004
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
288/5/F899    most recent
00370.2004v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Saifudeen, Z.
Right arrow Articles by El-Dahr, S. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Saifudeen, Z.
Right arrow Articles by El-Dahr, S. S.
Submitted on October 5, 2004
Accepted on December 30, 2004

Combinatorial Control of the Bradykinin B2 Receptor Promoter by p53, CREB, KLF-4 and CBP: Implications for Terminal Nephron Differentiation

Zubaida Saifudeen1, Susana Dipp1, Hao Fan1, and Samir S. El-Dahr1*

1 Department of Pediatrics, Section of Pediatric Nephrology, Tulane University Health Sciences Center, New Orleans, LA, USA

* To whom correspondence should be addressed. E-mail: seldahr{at}tulane.edu.

Despite a wealth of knowledge regarding the early steps of epithelial differentiation, little is known about the mechanisms responsible for terminal nephron differentiation. The bradykinin B2 receptor (B2R) regulates renal function and integrity and its expression is induced during terminal nephron differentiation. This study investigates the transcriptional regulation of the B2R during kidney development. The rat B2R 5'- flanking region has a highly conserved cis-acting enhancer in the proximal promoter consisting of contiguous binding sites for the transcription factors Cyclic AMP Response Element Binding Protein (CREB), p53, and Kruppel-like Factor (KLF-4). The B2R enhancer drives reporter gene expression in IMCD-3 cells but is considerably weaker in other cell types. Site-directed mutagenesis and expression of dominant negative mutants demonstrated the requirement of CREB DNA binding and Ser-133 phosphorylation for optimal enhancer function. Moreover, helical phasing experiments showed that disruption of the spatial organization of the enhancer inhibits B2R promoter activity. Several lines of evidence indicate that cooperative interactions among the three transcription factors occur in vivo during terminal nephron differentiation: a) CREB, p53 and KLF-4 are co-expressed in B2R-positive differentiating cells, b) The maturational expression of B2R correlates with CREB/p53/KLF-4 DNA-binding activity, c) Assembly of CREB, p53 and KLF-4 on chromatin at the endogenous B2R promoter is developmentally regulated and is accompanied by CBP recruitment and histone hyperacetylation, and d) CREB and p53 occupancy of the B2R enhancer is cooperative. These results demonstrate that combinatorial interactions among the transcription factors, CREB, p53 and KLF-4, and the co-activator CBP, may be critical for the regulation of B2R gene expression during terminal nephron differentiation.




This article has been cited by other articles:


Home page
J. Am. Soc. Nephrol.Home page
A. Pozzi and R. Zent
Integrins, Extracellular Matrix, and Terminal Differentiation of Renal Epithelial Cells
J. Am. Soc. Nephrol., June 1, 2008; 19(6): 1043 - 1044.
[Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
S. S. El-Dahr, K. Aboudehen, and Z. Saifudeen
Transcriptional control of terminal nephron differentiation
Am J Physiol Renal Physiol, June 1, 2008; 294(6): F1273 - F1278.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
B. Shen, L. M. Harrison-Bernard, A. J. Fuller, V. Vanderpool, Z. Saifudeen, and S. S. El-Dahr
The Bradykinin B2 Receptor Gene Is a Target of Angiotensin II Type 1 Receptor Signaling
J. Am. Soc. Nephrol., April 1, 2007; 18(4): 1140 - 1149.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
H. Fan, J. Stefkova, and S. S. El-Dahr
Susceptibility to metanephric apoptosis in bradykinin B2 receptor null mice via the p53-Bax pathway
Am J Physiol Renal Physiol, September 1, 2006; 291(3): F670 - F682.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
R. Zamorano, S. Suchindran, and J. V. Gainer
3'-Untranslated region of the type 2 bradykinin receptor is a potent regulator of gene expression
Am J Physiol Renal Physiol, February 1, 2006; 290(2): F456 - F464.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
C. M. Bates
Transcriptional control of renal collecting duct development
Am J Physiol Renal Physiol, May 1, 2005; 288(5): F897 - F898.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.